Emerging pharmacological therapies for ARDS: COVID-19 and beyond. (2020)

First Author: Horie S
Attributed to:  A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00134-020-06141-z

PubMed Identifier: 32654006

Publication URI: http://europepmc.org/abstract/MED/32654006

Type: Journal Article/Review

Volume: 46

Parent Publication: Intensive care medicine

Issue: 12

ISSN: 0342-4642